Clinical trial
Metabolite Profiling of the Impact of Oligofructose Enriched Inulin in Crohn's Disease Patients
NCT01487759 is registered in ClinicalTrials.gov with KU Leuven as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Metabolite Profiling of the Impact of Oligofructose Enriched Inulin in Crohn's Disease Patients
- Lead sponsor
- KU Leuven
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 31, 2008
- Completion date
- July 31, 2009
- Enrollment
- 67 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.